TONGLI PHARMACEUTICALS (USA), INC.
CIK 0001052284
Revenue (TTM)
—
Q3 Feb 2014
Net Income (TTM)
$1.01M
−30.6% YoY
Q3 Feb 2014
EPS Diluted (TTM)
—
Q3 Feb 2014
Gross Margin
—
Q3 Feb 2014
Operating Margin
—
Q3 Feb 2014
Net Margin
—
Q3 Feb 2014
Free Cash Flow (TTM)
$492.24K
Q3 Feb 2014
Cash
—
Q3 Feb 2014
Total Debt
—
Q3 Feb 2014
Shares Outstanding
14.73M sh
Q3 Feb 2014
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.